DRUGS APPROVED BY THE FDA FOR WEIGHT LOSS
DRUGS APPROVED BY THE FDA FOR WEIGHT LOSS
Drugs approved for use in weight loss programs can be broken
down into the following categories:
1. Anorexiants (drugs that work on chemicals in the brain)
a. Amphetamines
1. Benzphetamine (Didrex®)
2. Diethylpriopion (Tenuate®; Tenuate Dospan®)
3. Methamphetamine (Desoxyn®)
4. Phentermine (Adipex®; Adipex®-P or Ionamin®)
b. Sibutramine (Meridia®)
2. Lipase Inhibitors (drugs [...]
Quitting smoking rimonabant
Quitting smoking rimonabantQuitting smoking is difficult, and the fact that quitting smoking often leads to unhealthy weight gain is often a justification for people to delay their attempts to break free from their habit.
Smoking is the leading preventable cause of death in the world today, and if [...]
Diet Drug Taranabant Produces Weight Loss at One-Tenth the Acomplia Dosage
Merck diet drug taranabant, which targets the same CB-1 receptor as Sanofi’s obesity treatment Acomplia (rimonabant) , also produces psychiatric side effects but results in almost-as-good weight loss at one-tenth the dosage, according to study results presented to the American College of Cardiology.
Merck [...]
Zimulti Acomplia News — Oct. 2007 — News About Rimonabant
Diet Drug Taranabant Yields Encouraging Results With ‘Generally Mild’ Side-Effects Taranabant, which a year from now may have surged past (Acomplia) rimonabant as the world’s most eagerly awaited diet drug, made a low-key debut Oct. 24th when researchers reported that participants in a clinical [...]
Merck Halts Development of Its Diet Drug Acomplia (Rimonabant, Zimulti) Taranabant
In an announcement that cannot fail to have reverberations for Acomplia (Rimonabant, Zimulti) , Merck & Co. announced on Oct. 2 that it has halted development of its experimental antiobesity drug taranabant because of concern over side-effects.
Merck said taranabant, which like rimonabant acts by blocking certain cannabinoid receptors [...]
FAQ’s of Acomplia
Q. What is Acomplia (Rimonabant)?
A. Acomplia, an appetite suppressant diet pill and smoking cessation drug which works by blocking CB1 receptor of the brain commonly called the ‘pleasure centre’ of the brain and interfering with the cycle of craving thus making hunger or smoking pangs [...]
Rimonabant Acomplia Side Effects
Rimonabant works by blocking endogenous cannabinoid binding to neuronal CB1 receptors. Activation of these receptors by endoegenous cannabinoids, such as anadamide, increases appetite. It is the most advanced endocannabinoid receptor antagonist in clinical development and offers a novel therapeutic approach to appetite control and weight reduction. The drug also has potential [...]
January 19th FDA plans to approval of diet drug Acomplia (rimonabant) Zimulti name in USA
Merck reiterated on January. 19th that it plans to file for FDA approval of diet drug Acomplia (rimonabant) “Taranabant” in 2008 even though some adverse psychiatric side-effects have been observed similar to those found with Sanofi’s diet drug Acomplia (rimonabant).
Taranabant, a CB-1 receptor inverse agonist, [...]
